Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yana A. Kisarova"'
Autor:
Svetlana Ya. Zhanaeva, Tatyana V. Alexeenko, Tatyana A. Korolenko, Nina I. Dubrovina, Marina S. Cherkanova, Thomas P. Johnston, Yana A. Kisarova, Elena E. Filjushina, Eva Machová, Natalya A. Zhukova
Publikováno v:
Interdisciplinary Toxicology
Chronic administration of the poloxamer 407 (P-407), a block copolymer, to elevate serum lipids in mice is a well-established mouse model of hyperlipidemia and atherosclerosis. We tested the hypothesis that the activity of several types of proteases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109a81b0c1e52592b469ee316c9f447d
https://pubmed.ncbi.nlm.nih.gov/24170975
https://pubmed.ncbi.nlm.nih.gov/24170975
Autor:
Anna A Monoszon, V. K. Spiridonov, Ivan V. Brak, Marina S. Cherkanova, Svetlana Ya. Zhanaeva, Natalia Alexandrovna Zhukova, Natalia A. Tuzikova, F. V. Tuzikov, Thomas P. Johnston, Yana A. Kisarova, Tatyana A. Korolenko, Elena E. Filjushina, Tatyana V. Alexeenko
Publikováno v:
Canadian journal of physiology and pharmacology. 90(11)
The effects of repeated administration of poloxamer 407 (P-407) on lipoprotein-cholesterol (LP-C) and lipoprotein-triglyceride (LP-TG) fractions and subfractions, as well as the effect on liver and heart proteases, were studied. Repeated administrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e5004428977116af7f7a52c33770f00
https://pubmed.ncbi.nlm.nih.gov/23181274
https://pubmed.ncbi.nlm.nih.gov/23181274